{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T20:19:08Z","timestamp":1790713148719,"version":"4.1.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2022,11,18]],"date-time":"2022-11-18T00:00:00Z","timestamp":1668729600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,11,18]],"date-time":"2022-11-18T00:00:00Z","timestamp":1668729600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100009602","name":"Howard and Georgeanna Jones Foundation for Reproductive Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009602","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Reprod. Sci."],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1007\/s43032-022-01120-9","type":"journal-article","created":{"date-parts":[[2022,11,18]],"date-time":"2022-11-18T21:44:41Z","timestamp":1668807881000},"page":"1495-1505","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["A Systematic Review of Minimally Invasive Approaches to Uterine Fibroid Treatment for Improving Quality of Life and Fibroid-Associated Symptoms"],"prefix":"10.1007","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5950-775X","authenticated-orcid":false,"given":"Joshua M.","family":"Morris","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarina","family":"Fleckenstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2113-4345","authenticated-orcid":false,"given":"Bhuchitra","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5969-376X","authenticated-orcid":false,"given":"James","family":"Segars","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,18]]},"reference":[{"key":"1120_CR1","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1067\/mob.2003.99","volume":"188","author":"DD Baird","year":"2003","unstructured":"Baird DD, Dunson DB, Hill MC, Cousins D, Schectman JM. High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence. Am J Obstet Gynecol. 2003;188:100\u20137. https:\/\/doi.org\/10.1067\/mob.2003.99.","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"1120_CR2","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/j.ajog.2020.05.044","volume":"223","author":"VA Go","year":"2020","unstructured":"Go VA, et al. A systematic review of the psychosocial impact of fibroids before and after treatment. Am J Obstet Gynecol. 2020;223(5):674-708.e8. https:\/\/doi.org\/10.1016\/j.ajog.2020.05.044.","journal-title":"Am J Obstet Gynecol"},{"key":"1120_CR3","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1097\/GCO.0000000000000070","volume":"26","author":"NA Clark","year":"2014","unstructured":"Clark NA, Mumford SL, Segars JH. Reproductive impact of MRI-guided focused ultrasound surgery for fibroids. Curr Opin Obstet Gynecol. 2014;26:151\u201361. https:\/\/doi.org\/10.1097\/GCO.0000000000000070.","journal-title":"Curr Opin Obstet Gynecol"},{"key":"1120_CR4","doi-asserted-by":"publisher","unstructured":"Jun F, Yamin L, Yushun Z, Lijuan W, Xingye W, Hao Q, Wenli G. Effect of selective uterine artery embolization on symptomatic uterine fibroids. J Med Coll PLA. 2009;346\u201353. https:\/\/doi.org\/10.1016\/S1000-1948(10)60005-6.","DOI":"10.1016\/S1000-1948(10)60005-6"},{"key":"1120_CR5","doi-asserted-by":"publisher","first-page":"267","DOI":"10.2214\/AJR.08.1841","volume":"193","author":"M Popovic","year":"2009","unstructured":"Popovic M, Berzaczy D, Puchner S, Zadina A, Lammer J, Bucek RA. Long-term quality of life assessment among patients undergoing uterine fibroid embolization. Am J Roentgenol. 2009;193(1):267\u201371. https:\/\/doi.org\/10.2214\/AJR.08.1841.","journal-title":"Am J Roentgenol"},{"issue":"3","key":"1120_CR6","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.ijgo.2003.09.006","volume":"84","author":"A Prollius","year":"2004","unstructured":"Prollius A, de Vries C, Loggenberg E, Nel M, du Plessis A, Van Rensburg DJ, Wessels PH. Uterine artery embolization for symptomatic fibroids. Int J Gynaecol Obstet. 2004;84(3):236\u201340. https:\/\/doi.org\/10.1016\/j.ijgo.2003.09.006.","journal-title":"Int J Gynaecol Obstet."},{"key":"1120_CR7","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/S1701-2163(15)31021-5","volume":"35","author":"P Rasuli","year":"2013","unstructured":"Rasuli P, Sabri A, Hammond I, French GJ, Gamache N, Jolly EE. Outpatient uterine artery embolization for symptomatic fibroids: short- and long-term single institution-based outcomes. J Obstet Gynaecol Canada. 2013;35:156\u201363. https:\/\/doi.org\/10.1016\/S1701-2163(15)31021-5.","journal-title":"J Obstet Gynaecol Canada"},{"key":"1120_CR8","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1016\/j.jvir.2013.02.018","volume":"24","author":"C Scheurig-Muenkler","year":"2013","unstructured":"Scheurig-Muenkler C, Koesters C, Powerski MJ, Grieser C, Froeling V, Kroencke TJ. Clinical long-term outcome after uterine artery embolization: sustained symptom control and improvement of quality of life. J Vasc Interv Radiol. 2013;24:765\u201371. https:\/\/doi.org\/10.1016\/j.jvir.2013.02.018.","journal-title":"J Vasc Interv Radiol"},{"key":"1120_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40349-016-0072-9","volume":"4","author":"R Chen","year":"2016","unstructured":"Chen R, Keserci B, Bi H, Han X, Wang X, Bai W, et al. The safety and effectiveness of volumetric magnetic resonance-guided high-intensity focused ultrasound treatment of symptomatic uterine fibroids: early clinical experience in China. J Ther Ultrasound. 2016;4:1\u20139. https:\/\/doi.org\/10.1186\/s40349-016-0072-9.","journal-title":"J Ther Ultrasound"},{"key":"1120_CR10","doi-asserted-by":"publisher","first-page":"550","DOI":"10.47102\/annals-acadmedsg.V43N11p550","volume":"43","author":"NLR Han","year":"2014","unstructured":"Han NLR, Ong CL. Magnetic resonance-guided focused ultrasound surgery (MRgFUS) of uterine fibroids in Singapore. Ann Acad Med Singapore. 2014;43:550\u20138.","journal-title":"Ann Acad Med Singapore"},{"key":"1120_CR11","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/j.fertnstert.2015.11.014","volume":"105","author":"VL Jacoby","year":"2016","unstructured":"Jacoby VL, Kohi MP, Poder L, Jacoby A, Lager J, Schembri M, et al. PROMISe trial: a pilot, randomized, placebo-controlled trial of magnetic resonance guided focused ultrasound for uterine fibroids. Fertil Steril. 2016;105:773\u201380. https:\/\/doi.org\/10.1016\/j.fertnstert.2015.11.014.","journal-title":"Fertil Steril"},{"key":"1120_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/2050-5736-1-23","volume":"1","author":"R Machtinger","year":"2013","unstructured":"Machtinger R, Fennessy FM, Stewart EA, Missmer SA, Correia KF, Tempany CMC. MR-guided focused ultrasound (MRgFUS) is effective for the distinct pattern of uterine fibroids seen in African-American women: data from phase III\/IV, non-randomized, multicenter clinical trials. J Ther Ultrasound. 2013;1:1\u20138. https:\/\/doi.org\/10.1186\/2050-5736-1-23.","journal-title":"J Ther Ultrasound"},{"key":"1120_CR13","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.jvir.2013.11.011","volume":"25","author":"MJ Park","year":"2014","unstructured":"Park MJ, Kim YS, Rhim H, Lim HK. Safety and therapeutic efficacy of complete or near-complete ablation of symptomatic uterine fibroid tumors by MR imaging-guided high-intensity focused US Therapy. J Vasc Interv Radiol. 2014;25:231\u20139. https:\/\/doi.org\/10.1016\/j.jvir.2013.11.011.","journal-title":"J Vasc Interv Radiol"},{"key":"1120_CR14","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1097\/01.AOG.0000222381.94325.4f","volume":"108","author":"OC Smart","year":"2006","unstructured":"Smart OC, Hindley JT, Regan L, Gedroyc WG. Gonadotrophin-releasing hormone and magnetic-resonance-guided ultrasound surgery for uterine leiomyomata. Obstet Gynecol. 2006;108:49\u201354. https:\/\/doi.org\/10.1097\/01.AOG.0000222381.94325.4f.","journal-title":"Obstet Gynecol"},{"key":"1120_CR15","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.7863\/ultra.14.12080","volume":"34","author":"Y Xu","year":"2015","unstructured":"Xu Y, Fu Z, Yang L, Huang Z, Chen WZ, Wang Z. Feasibility, safety, and efficacy of accurate uterine fibroid ablation using magnetic resonance imaging-guided high-intensity focused ultrasound with shot sonication. J Ultrasound Med. 2015;34:2293\u2013303. https:\/\/doi.org\/10.7863\/ultra.14.12080.","journal-title":"J Ultrasound Med"},{"key":"1120_CR16","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1080\/02656736.2017.1421323","volume":"34","author":"M He","year":"2018","unstructured":"He M, Jacobson H, Zhang C, Setzen R, Zhang L. A retrospective study of ultrasound-guided high intensity focussed ultrasound ablation for multiple uterine fibroids in South Africa. Int J Hyperth. 2018;34:1304\u201310. https:\/\/doi.org\/10.1080\/02656736.2017.1421323.","journal-title":"Int J Hyperth"},{"key":"1120_CR17","doi-asserted-by":"publisher","unstructured":"Hou R, Wang L, Li S, Rong F, Wang Y, Qin X, et al. Pilot study: safety and effectiveness of simple ultrasound-guided high-intensity focused ultrasound ablating uterine leiomyoma with a diameter greater than 10 cm. Br J Radiol 2018;91. https:\/\/doi.org\/10.1259\/bjr.20160950.","DOI":"10.1259\/bjr.20160950"},{"key":"1120_CR18","doi-asserted-by":"publisher","first-page":"3214","DOI":"10.1016\/j.ultrasmedbio.2019.08.022","volume":"45","author":"JS Lee","year":"2019","unstructured":"Lee JS, Hong GY, Lee KH, Song JH, Kim TE. Safety and efficacy of ultrasound-guided high-intensity focused ultrasound treatment for uterine fibroids and adenomyosis. Ultrasound Med Biol. 2019;45:3214\u201321. https:\/\/doi.org\/10.1016\/j.ultrasmedbio.2019.08.022.","journal-title":"Ultrasound Med Biol"},{"key":"1120_CR19","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/j.jmig.2014.02.015","volume":"21","author":"JM Berman","year":"2014","unstructured":"Berman JM, Guido RS, Garza Leal JG, Pemueller RR, Whaley FS, Chudnoff SG, et al. Three-year outcome of the Halt trial: a prospective analysis of radiofrequency volumetric thermal ablation of myomas. J Minim Invasive Gynecol. 2014;21:767\u201374. https:\/\/doi.org\/10.1016\/j.jmig.2014.02.015.","journal-title":"J Minim Invasive Gynecol"},{"key":"1120_CR20","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s10397-014-0873-1","volume":"12","author":"M Bongers","year":"2015","unstructured":"Bongers M, Br\u00f6lmann H, Gupta J, Garza-Leal JG, Toub D. Transcervical, intrauterine ultrasound-guided radiofrequency ablation of uterine fibroids with the VizAblate\u00ae System: three- and six-month endpoint results from the FAST-EU study. Gynecol Surg. 2015;12:61\u201370. https:\/\/doi.org\/10.1007\/s10397-014-0873-1.","journal-title":"Gynecol Surg"},{"key":"1120_CR21","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s10397-015-0915-3","volume":"13","author":"H Br\u00f6lmann","year":"2016","unstructured":"Br\u00f6lmann H, Bongers M, Garza-Leal JG, Gupta J, Veersema S, Quartero R, et al. The FAST-EU trial: 12-month clinical outcomes of women after intrauterine sonography-guided transcervical radiofrequency ablation of uterine fibroids. Gynecol Surg. 2016;13:27\u201335. https:\/\/doi.org\/10.1007\/s10397-015-0915-3.","journal-title":"Gynecol Surg"},{"key":"1120_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/medicina56030122","volume":"56","author":"A Fasciani","year":"2020","unstructured":"Fasciani A, Turtulici G, Siri G, Ferrero S, Sirito R. A prospective intervention trial on tailored radiofrequency ablation of uterine myomas. Med. 2020;56:1\u201311. https:\/\/doi.org\/10.3390\/medicina56030122.","journal-title":"Med"},{"key":"1120_CR23","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.jmig.2011.02.006","volume":"18","author":"JG Garza Leal","year":"2011","unstructured":"Garza Leal JG, Hernandez Leon I, Castillo Saenz L, Lee BB. Laparoscopic ultrasound-guided radiofrequency volumetric thermal ablation of symptomatic uterine leiomyomas: feasibility study using the Halt 2000 Ablation System. J Minim Invasive Gynecol. 2011;18:364\u201371. https:\/\/doi.org\/10.1016\/j.jmig.2011.02.006.","journal-title":"J Minim Invasive Gynecol"},{"key":"1120_CR24","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1016\/j.jmig.2019.07.025","volume":"27","author":"VL Jacoby","year":"2020","unstructured":"Jacoby VL, Parvataneni R, Oberman E, Saberi NS, Varon S, Schembri M, et al. Laparoscopic radiofrequency ablation of uterine leiomyomas: clinical outcomes during early adoption into surgical practice. J Minim Invasive Gynecol. 2020;27:915\u201325. https:\/\/doi.org\/10.1016\/j.jmig.2019.07.025.","journal-title":"J Minim Invasive Gynecol"},{"key":"1120_CR25","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1080\/02656736.2018.1479778","volume":"35","author":"G Turtulici","year":"2018","unstructured":"Turtulici G, Orlandi D, Dedone G, Mauri G, Fasciani A, Sirito R, et al. Ultrasound-guided transvaginal radiofrequency ablation of uterine fibroids assisted by virtual needle tracking system: a preliminary study. Int J Hyperth. 2018;35:97\u2013104. https:\/\/doi.org\/10.1080\/02656736.2018.1479778.","journal-title":"Int J Hyperth"},{"key":"1120_CR26","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1148\/radiol.2015142537","volume":"279","author":"XJ Wu","year":"2016","unstructured":"Wu XJ, Guo Q, Cao BS, Tan LX, Zhang HY, Cai YR, et al. Uterine leiomyomas: safety and efficacy of us-guided suprapubic transvaginal radiofrequency ablation at 1-year follow-up. Radiology. 2016;279:952\u201360. https:\/\/doi.org\/10.1148\/radiol.2015142537.","journal-title":"Radiology"},{"key":"1120_CR27","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1080\/02656736.2016.1212276","volume":"32","author":"H Liu","year":"2016","unstructured":"Liu H, Zhang J, Han ZY, Zhang BS, Zhang W, Qi CS, et al. Effectiveness of ultrasound-guided percutaneous microwave ablation for symptomatic uterine fibroids: a multicentre study in China. Int J Hyperth. 2016;32:876\u201380. https:\/\/doi.org\/10.1080\/02656736.2016.1212276.","journal-title":"Int J Hyperth"},{"key":"1120_CR28","doi-asserted-by":"publisher","first-page":"6189","DOI":"10.3892\/ol.2018.8122","volume":"15","author":"B Liang","year":"2018","unstructured":"Liang B, Xie YG, Xu XP, Hu CH. Diagnosis and treatment of submucous myoma of the uterus with interventional ultrasound. Oncol Lett. 2018;15:6189\u201394. https:\/\/doi.org\/10.3892\/ol.2018.8122.","journal-title":"Oncol Lett"},{"key":"1120_CR29","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1111\/1471-0528.14689","volume":"125","author":"J Chen","year":"2018","unstructured":"Chen J, Li Y, Wang Z, McCulloch P, Hu L, Chen W, et al. Evaluation of high-intensity focused ultrasound ablation for uterine fibroids: an IDEAL prospective exploration study. BJOG An Int J Obstet Gynaecol. 2018;125:354\u201364. https:\/\/doi.org\/10.1111\/1471-0528.14689.","journal-title":"BJOG An Int J Obstet Gynaecol"},{"key":"1120_CR30","doi-asserted-by":"publisher","first-page":"745.e1","DOI":"10.1016\/j.ajog.2016.06.051","volume":"215","author":"AM de Bruijn","year":"2016","unstructured":"de Bruijn AM, Ankum WM, Reekers JA, Birnie E, van der Kooij SM, Volkers NA, et al. Uterine artery embolization vs hysterectomy in the treatment of symptomatic uterine fibroids: 10-year outcomes from the randomized EMMY trial. Am J Obstet Gynecol. 2016;215:745.e1-745.e12. https:\/\/doi.org\/10.1016\/j.ajog.2016.06.051.","journal-title":"Am J Obstet Gynecol"},{"key":"1120_CR31","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1056\/NEJMoa062003","volume":"356","author":"RD Edwards","year":"2007","unstructured":"Edwards RD, Moss JG, Lumsden MA, Wu O, Murray LS, Twaddle S, et al. Uterine-artery embolization versus surgery for symptomatic uterine fibroids. N Engl J Med. 2007;356:360\u201370. https:\/\/doi.org\/10.1056\/NEJMoa062003.","journal-title":"N Engl J Med"},{"key":"1120_CR32","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1055\/s-0035-1545931","volume":"75","author":"M Hahn","year":"2015","unstructured":"Hahn M, Brucker S, Kraemer D, Wallwiener M, Taran FA, Wallwiener CW, et al. Radiofrequency volumetric thermal ablation of fibroids and laparoscopic myomectomy: long-term follow-up from a randomized trial. Geburtshilfe Frauenheilkd. 2015;75:442\u20139. https:\/\/doi.org\/10.1055\/s-0035-1545931.","journal-title":"Geburtshilfe Frauenheilkd"},{"key":"1120_CR33","doi-asserted-by":"publisher","first-page":"2649","DOI":"10.1007\/s00330-014-3295-6","volume":"24","author":"ME Ikink","year":"2014","unstructured":"Ikink ME, Nijenhuis RJ, Verkooijen HM, Voogt MJ, Reuwer PJHM, Smeets AJ, et al. Volumetric MR-guided high-intensity focused ultrasound versus uterine artery embolisation for treatment of symptomatic uterine fibroids: comparison of symptom improvement and reintervention rates. Eur Radiol. 2014;24:2649\u201357. https:\/\/doi.org\/10.1007\/s00330-014-3295-6.","journal-title":"Eur Radiol"},{"key":"1120_CR34","doi-asserted-by":"publisher","first-page":"174.e1","DOI":"10.1016\/j.ajog.2018.10.032","volume":"220","author":"S Laughlin-Tommaso","year":"2019","unstructured":"Laughlin-Tommaso S, Barnard EP, AbdElmagied AM, Vaughan LE, Weaver AL, Hesley GK, et al. FIRSTT study: randomized controlled trial of uterine artery embolization vs focused ultrasound surgery. Am J Obstet Gynecol. 2019;220:174.e1-174.e13. https:\/\/doi.org\/10.1016\/j.ajog.2018.10.032.","journal-title":"Am J Obstet Gynecol"},{"key":"1120_CR35","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.ajog.2004.03.037","volume":"191","author":"JB Spies","year":"2004","unstructured":"Spies JB, Cooper JM, Worthington-Kirsch R, Lipman JC, Mills BB, Benenati JF. Outcome of uterine embolization and hysterectomy for leiomyomas: results of a multicenter study. Am J Obstet Gynecol. 2004;191:22\u201331. https:\/\/doi.org\/10.1016\/j.ajog.2004.03.037.","journal-title":"Am J Obstet Gynecol"},{"key":"1120_CR36","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1097\/AOG.0b013e3181ed36b3","volume":"116","author":"JB Spies","year":"2010","unstructured":"Spies JB, Bradley LD, Guido R, Maxwell GL, Levine BA, Coyne K. Outcomes from leiomyoma therapies. Obstet Gynecol. 2010;116:641\u201352. https:\/\/doi.org\/10.1097\/AOG.0b013e3181ed36b3.","journal-title":"Obstet Gynecol"},{"key":"1120_CR37","doi-asserted-by":"publisher","first-page":"105.e1","DOI":"10.1016\/j.ajog.2010.01.049","volume":"203","author":"SM Van Der Kooij","year":"2010","unstructured":"Van Der Kooij SM, Hehenkamp WJK, Volkers NA, Birnie E, Ankum WM, Reekers JA. Uterine artery embolization vs hysterectomy in the treatment of symptomatic uterine fibroids: 5-year outcome from the randomized EMMY trial. Am J Obstet Gynecol. 2010;203:105.e1-105.e13. https:\/\/doi.org\/10.1016\/j.ajog.2010.01.049.","journal-title":"Am J Obstet Gynecol"},{"key":"1120_CR38","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.jmig.2013.09.004","volume":"21","author":"F Wang","year":"2014","unstructured":"Wang F, Tang L, Wang L, Wang X, Chen J, Liu X, et al. Ultrasound-guided high-intensity focused ultrasound vs laparoscopic myomectomy for symptomatic uterine myomas. J Minim Invasive Gynecol. 2014;21:279\u201384. https:\/\/doi.org\/10.1016\/j.jmig.2013.09.004.","journal-title":"J Minim Invasive Gynecol"},{"key":"1120_CR39","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.ejrad.2014.11.041","volume":"84","author":"WP Zhao","year":"2015","unstructured":"Zhao WP, Han ZY, Zhang J, Liang P. A retrospective comparison of microwave ablation and high intensity focused ultrasound for treating symptomatic uterine fibroids. Eur J Radiol. 2015;84:413\u20137. https:\/\/doi.org\/10.1016\/j.ejrad.2014.11.041.","journal-title":"Eur J Radiol"},{"key":"1120_CR40","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/S0029-7844(01)01702-1","volume":"99","author":"J Spies","year":"2002","unstructured":"Spies J. The UFS-QOL, a new disease-specific symptom and health-related quality of life questionnaire for leiomyomata. Obstet Gynecol. 2002;99:290\u2013300. https:\/\/doi.org\/10.1016\/S0029-7844(01)01702-1.","journal-title":"Obstet Gynecol"},{"key":"1120_CR41","doi-asserted-by":"publisher","first-page":"g3253","DOI":"10.1136\/bmj.g3253","volume":"348","author":"K Wartolowska","year":"2014","unstructured":"Wartolowska K, Judge A, Hopewell S, Collins GS, Dean BJ, Rombach I, et al. Use of placebo controls in the evaluation of surgery: systematic review. BMJ. 2014;348:g3253. https:\/\/doi.org\/10.1136\/bmj.g3253.","journal-title":"BMJ"},{"key":"1120_CR42","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/bs.irn.2018.01.003","volume":"138","author":"I Kirsch","year":"2018","unstructured":"Kirsch I. Response expectancy and the placebo effect. Int Rev Neurobiol. 2018;138:81\u201393. https:\/\/doi.org\/10.1016\/bs.irn.2018.01.003.","journal-title":"Int Rev Neurobiol"}],"container-title":["Reproductive Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43032-022-01120-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s43032-022-01120-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43032-022-01120-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,4]],"date-time":"2023-05-04T19:15:19Z","timestamp":1683227719000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s43032-022-01120-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,18]]},"references-count":42,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["1120"],"URL":"https:\/\/doi.org\/10.1007\/s43032-022-01120-9","relation":{},"ISSN":["1933-7191","1933-7205"],"issn-type":[{"value":"1933-7191","type":"print"},{"value":"1933-7205","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,18]]},"assertion":[{"value":"10 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"N\/A.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"N\/A.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"N\/A.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"JS reports prior\u00a0research funding for clinical trials from BioSpecifics Technologies Corporation, Bayer, Allergan, AbbVie Inc, and ObsEva. JS has served as a consultant to Bayer and Myovant Sciences. JS reports service on the  American Gynecological and Obstetrical Society. The other authors report no conflict of interest.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}